Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|October 6, 2009

Humedica Launches Next-Generation Clinical Informatics Platform

BOSTON, MA

Humedica, a next-generation health care informatics company, announced the company’s official launch, along with the previous completion of its $30 million round of venture capital and its clinical analytics platform.

In response to a growing demand for essential clinical information, Humedica has developed a clinical informatics solution that addresses the specific needs of inpatient and outpatient health care providers, pharmaceutical and biotechnology firms, medical device manufacturers, government agencies and financial services firms. Currently being implemented in select hospitals and medical groups throughout the country, Humedica’s software-as-a-service (SaaS) solution connects patient information across varied medical settings and time periods to generate a comprehensive view of patient care.

“...Humedica offers a complete picture of health care delivery, bringing together clinical, operational, and financial data to help answer both pressing real-time questions and to address topics at the center of health care reform that require comparative analyses and benchmarking information,” said Michael Weintraub, President and CEO of Humedica.

Humedica has developed an analytics platform that effectively overcomes barriers of accessing relevant clinical information, transforming real-time and retrospective data into actionable knowledge. Humedica applies sophisticated techniques to mine, standardize, and aggregate health care data from disparate IT systems, all within a HIPAA-compliant, and highly secure environment.

Humedica’s SaaS-based clinical informatics portfolio offers analytics, reporting, and benchmarking.

The company also disclosed it received $30 million in capital from Bain Capital Ventures, General Catalyst Partners, North Bridge Venture Partners, and Leerink Swann.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.